Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves?

Inflammation

Volumn 35, Issue 3, 2012, Pages 834-840

  Natorska, Joanna ^a,b   Wypasek, Ewa ^a,b   Grudzień, Grzegorz ^a,b   Sobczyk, Dorota ^b   Marek, Grzegorz ^b   Filip, Grzegorz ^b   Sadowski, Jerzy ^a,b   Undas, Anetta ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Aortic stenosis; C reactive protein; Diabetes mellitus; Inflammation

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; MESSENGER RNA; PROTHROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE; AORTA VALVE REPLACEMENT; ARTICLE; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; C-REACTIVE PROTEIN; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEINS; MALE; MIDDLE AGED; PROTHROMBIN; RNA, MESSENGER; THROMBOPLASTIN;

EID: 84863806804     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9384-7     Document Type: Article

References (34)

1. Otto, C.M., B.K. Lind, D.W. Kitzman, B.J. Gersh, and D.S. Sisovick. 1999. Associations of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. The New England Journal of Medicine 341: 142-147. (Pubitemid 29325741)
2. Ortlepp, J.R., M. Pillich, F. Schmitz, V. Mevissen, R. Koos, S. Weiss, L. Stork, R. Dronskowski, G. Langebartels, R. Autschbach, V. Brandenburg, S. Woodruff, J.J. Kaden, and R. Hoffmann. 2006. Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis. The Journal of Heart Valve Disease 15: 502-508. (Pubitemid 44122679)
3. Yetkin, E., and J. Waltenberger. 2009. Molecular and cellular mechanisms of aortic stenosis. International Journal of Cardiology 135: 4-13.
4. Mohty, D., P. Pibarot, J.P. Després, C. Côté, B. Arsenault, A. Cartier, P. Cosnay, C. Couture, and P. Mathieu. 2008. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 187-193.
5. Pate, G.E. 2002. Association between aortic stenosis and hypertension. The Journal of Heart Valve Disease 11: 612-614.
6. Ngo, M.V., J.S. Gottdiener, R.D. Fletcher, D.J. Fernicola, and B.J. Gersh. 2001. Smoking and obesity are associated with progression of aortic stenosis. The American Journal of Geriatric Cardiology 10: 86-90. (Pubitemid 32215684)
7. Katz, R., N.D. Wong, R. Kronmal, J. Takasu, D.M. Shavelle, J.L. Probstfield, A.G. Bertoni, M.J. Budoff, and K.D. O'Brien. 2006. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 113: 2113-2119.
8. Jawień, J. 2008. New insights into immunological aspects of atherosclerosis. Polskie Archiwum Medycyny Wewnȩtrznej 118: 127-131. (Pubitemid 351488259)
9. Miłosz, D., L. Czupryniak, M. Saryusz-Wolska, G. Zasadzińska, A. Borkowska, E. Cieplucha, K. Chizyński, and J. Loba. 2007. Adiponectinemia, inflammatory process activity, and endothelial dysfunction in patients with type 2 diabetes and acute coronary syndrome with ST elevation in relation to the severity of lesions in the coronary arteries. Polskie Archiwum Medycyny Wewnȩtrznej 117: 343-349. (Pubitemid 350044620)
10. Cipolletta, C., K.E. Ryan, E.V. Hanna, and E.R. Trimble. 2005. Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes 54: 2779-2786. (Pubitemid 41233602)
11. Voleti, B., and A. Agrawal. 2005. Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter. Journal of Immunology 175: 3386-3390. (Pubitemid 41170561)
12. Guerrero-Romero, F., and M. Rodríguez-Morán. 2006. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes/Metabolism Research and Reviews 22: 471-476. (Pubitemid 44774051)
13. Bierhaus, A., T. Illmer, M. Kasper, T. Luther, P. Quehenberger, H. Tritschler, P. Wahl, R. Ziegler, M. Müller, and P.P. Nawroth. 1997. Advanced glycation end products-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96: 2262-2271. (Pubitemid 27425832)
14. Sommeijer, D.W., H.R. Hansen, R. van Oerle, K. Hamulyak, A.P. van Zanten, E. Meesters, H.M. Spronk, and H. Cate. 2006. Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes. Journal of Thrombosis and Haemostasis 4: 574-580.
15. Wolfe, M.L., N. Iqbal, W. Gefter, E.R. Mohler 3rd, D.J. Rader, and M.P. Reilly. 2002. Coronary artery calcification at electron beam computed tomography is increased in asymptomatic type 2 diabetics independent of traditional risk factors. Journal of Cardiovascular Risk 9: 369-376. (Pubitemid 36044392)
16. Kamalesh, M., C. Ng, H. El Masry, G. Eckert, and S. Sawada. 2009. Does diabetes accelerate progression of calcific aortic stenosis? European Journal of Echocardiography 10: 723-725.
17. Pradhan, A.D., J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker. 2001. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334. (Pubitemid 32656163)
18. Sanchez, P.L., and A.M. Mazzone. 2006. C-reactive protein in aortic valve disease. Cardiovascular Ultrasound 4: 37-40.
19. Toli, K., K.I. Paraskevas, M.V. Poulakou, G. Agrogiannis, N. Kavantzas, V. Xanthopoulos, D.G. Iliopoulos, I. Mantas, A. Papachristodoulou, E. Patsouris, D.P. Mikhailidis, and D.N. Perrea. 2008. Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment? Expert Opinion on Therapeutic Targets 12: 1209-1215.
20. Natorska, J., G. Marek, M. Hlawaty, D. Sobczyk, J. Sadowski, W. Tracz, and A. Undas. 2009. Evidence for tissue factor expression in aortic valves in patients with aortic stenosis. Polskie Archiwum Medycyny Wewnȩtrznej 119: 636-642.
21. Breyne, J., F. Juthier, D. Croseaux, S. Marechaux, Ch Zawadzki, E. Jeanpierre, A. Ung, P.V. Ennezat, S. Susen, E. Van Belle, H. Le Marec, A. Vincentelli, T. Le Tourneau, and B. Jude. 2010. Atherosclerotic-like process in aortic stenosis: Activation of the tissue factor-thrombin pathway and potential role through osteopontin alternation. Atherosclerosis 213: 369-376.
22. Teirstein, P., M. Yeager, P.G. Yock, and R.L. Popp. 1986. Doppler echocardiographic measurement of aortic valve area in aortic stenosis: a noninvasive application of the Gorlin formula. Journal of the American College of Cardiology 8: 1059-1065. (Pubitemid 16009090)
23. Lamprecht, M.R., D.M. Sabatini, and A.E. Carpenter. 2007. Cell profiler: Versalite software for automated biological image analysis. BioTechniques 42: 71-75.
24. Clark-Greuel, J.N., J.M. Connolly, E. Sorichillo, N.R. Narula, H.E. Rapoport, E.R. Mohler, J.H. Gorman, R.C. Gorman, and R.J. Levy. 2007. Transforming growth factor beta-1 mechanisms in aortic valve calcification: Increased alkaline phosphatase and related events. The Annals of Thoracic Surgery 7: 946-953. (Pubitemid 46328821)
25. Yasojima, K., C. Schwab, E.G. McGeer, and P.L. McGeer. 2001. Generation of C-reactive protein and complement components in atherosclerotic plaques. American Journal of Pathology 158: 1039-1051. (Pubitemid 32221796)
26. Mugabo, Y., L. Li, and G. Renier. 2010. The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Current Diabetes Reviews 6: 27-34.
27. Barzilay, J.I., L. Abraham, S.R. Heckbert, M. Cushman, L.H. Kuller, H.E. Resnick, and R.P. Tracy. 2011. The relation of markers of inflammation to the development of glucose disorders in the elderly: The Cardiovascular Health Study. Diabetes 50: 2384-2389.
28. Sjöholm, A., and T. Nyström. 2006. Inflammation and the etiology of type 2 diabetes. Diabetes/Metabolism Research and Reviews 22: 4-10. (Pubitemid 43154455)
29. Sweat, V., V. Starr, H. Bruehl, A. Arentoft, A. Tirsi, E. Javier, and A. Convit. 2008. C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation 31: 198-207.
30. Galante, A., A. Pietroiusti, M. Vellini, P. Piccolo, G. Possati, M. De Bonis, R.L. Grillo, C. Fontana, and C. Favalli. 2001. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. Journal of the American College of Cardiology 38: 1078-1082. (Pubitemid 32912714)
31. Kaden, J.J., C.E. Dempfle, R. Grobholz, C.S. Fischer, D.C. Vocke, R. Kiliç, A. Sarikoç, R. Piñol, S. Hagl, S. Lang, M. Brueckmann, and M. Borggrefe. 2005. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovascular Pathology 14: 80-87. (Pubitemid 40381303)
32. Marnell, L., C. Mold, and T.W. Du Clos. 2005. C-reactive protein: ligands, receptors and role in inflammation. Clinical Immunology 117: 104-111. (Pubitemid 41407719)
33. Natorska, J., G. Marek, M. Hlawaty, J. Sadowski, W. Tracz, and A. Undas. 2011. Fibrin presence within aortic valves in patients with aortic stenosis: Association with in vivo thrombin generation and fibrin clot properties. Thrombosis and Haemostasis 105: 254-260.
34. Drzewoski, J., and A. Drozdowska. 2010. Could glycated hemoglobin be used as a diagnostic tool in diabetes mellitus? Polskie Archiwum Medycyny Wewnȩtrznej 20: 109-114.